Onconetix Inc. (ONCO)
NASDAQ · Healthcare
Onconetix Inc. Income Statement 2023–2025
| Dec 2025 | Dec 2024 | Dec 2023 | |
|---|---|---|---|
| Revenues | |||
| Revenue | 815,371 | 2.5M | 58,465 |
| Gross Profit | 632,913 | 1.1M | -1.1M |
| Profitability | |||
| Operating Income | -17.9M | -56.5M | -36.0M |
| EBITDA | -17.8M | -55.8M | -36.0M |
| Net Income | -14.0M | -58.7M | -37.4M |
| Per Share Data | |||
| EPS (diluted) | $-16.56 | $-1823.39 | $-87.45 |
| Shares Outstanding (dil.) | 1M | 0M | 0M |
Onconetix Inc. Income Statement — FAQ
Onconetix Inc. (ONCO) income statement over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ONCO's income statement history?
The chart and table above show Onconetix Inc.'s income statement by year and by quarter, including the growth rate.